Pseudomonas aeruginosa Biofilm Formation and Persistence, along with the Production of Quorum Sensing-Dependent Virulence Factors, Are Disrupted by a Triterpenoid Coumarate Ester Isolated from Dalbergia trichocarpa, a Tropical Legume

PLoS One. 2015 Jul 17;10(7):e0132791. doi: 10.1371/journal.pone.0132791. eCollection 2015.

Abstract

Recently, extracts of Dalbergia trichocarpa bark have been shown to disrupt P. aeruginosa PAO1 quorum sensing (QS) mechanisms, which are key regulators of virulence factor expression and implicated in biofilm formation. One of the active compounds has been isolated and identified as oleanolic aldehyde coumarate (OALC), a novel bioactive compound that inhibits the formation of P. aeruginosa PAO1 biofilm and its maintenance as well as the expression of the las and rhl QS systems. Consequently, the production of QS-controlled virulence factors including, rhamnolipids, pyocyanin, elastase and extracellular polysaccharides as well as twitching and swarming motilities is reduced. Native acylhomoserine lactones (AHLs) production is inhibited by OALC but exogenous supply of AHLs does not restore the production of virulence factors by OALC-treated cultures, indicating that OALC exerts its effect beyond AHLs synthesis in the QS pathways. Further experiments provided a significant inhibition of the global virulence factor activator gacA by OALC. OALC disorganizes established biofilm structure and improves the bactericidal activity of tobramycin against biofilm-encapsulated PAO1 cells. Finally, a significant reduction of Caenorhabditis elegans paralysis was recorded when the worms were infected with OALC-pre-treated P. aeruginosa. Taken together, these results show that triterpenoid coumarate esters are suitable chemical backbones to target P. aeruginosa virulence mechanisms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acyl-Butyrolactones / metabolism
  • Aldehydes / pharmacology
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Biofilms / drug effects
  • Biofilms / growth & development*
  • Caenorhabditis elegans / drug effects
  • Coumaric Acids / chemistry
  • Coumaric Acids / isolation & purification
  • Coumaric Acids / pharmacology*
  • Coumaric Acids / therapeutic use
  • Dalbergia / chemistry*
  • Drug Synergism
  • Gene Expression Regulation, Bacterial / drug effects
  • Genes, Bacterial
  • Movement / drug effects
  • Oleanolic Acid / analogs & derivatives*
  • Oleanolic Acid / chemistry
  • Oleanolic Acid / isolation & purification
  • Oleanolic Acid / pharmacology
  • Oleanolic Acid / therapeutic use
  • Paralysis / drug therapy
  • Phenotype
  • Plant Bark / chemistry
  • Plant Extracts / pharmacology
  • Polysaccharides / chemistry
  • Pseudomonas aeruginosa / drug effects
  • Pseudomonas aeruginosa / genetics
  • Pseudomonas aeruginosa / pathogenicity
  • Pseudomonas aeruginosa / physiology*
  • Quorum Sensing / drug effects*
  • Tobramycin / pharmacology
  • Triterpenes / chemistry
  • Triterpenes / isolation & purification
  • Triterpenes / pharmacology*
  • Triterpenes / therapeutic use
  • Tropical Climate
  • Virulence Factors / metabolism*

Substances

  • 3-hydroxyolean-12-en-28-al 3-p-coumarate
  • Acyl-Butyrolactones
  • Aldehydes
  • Anti-Bacterial Agents
  • Coumaric Acids
  • Plant Extracts
  • Polysaccharides
  • Triterpenes
  • Virulence Factors
  • Oleanolic Acid
  • Tobramycin

Grants and funding

The study received funding from (Académie de Recherche et d’Enseignement Supérieur-Commission de Coopération au développement) ARES-CCD "Projet PIC 2009-Madagascar" and from Université Libre de Bruxelles Fonds Alice et David Van Buuren 2013-El Jaziri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.